首页> 外国专利> APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE

APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE

机译:淀粉样β-淀粉样蛋白(ABeta)原纤维形成的吗啡抑制剂及其在基于淀粉样变性的疾病中的用途

摘要

Described is a new class of small molecule inhibitors of amyloid β protein (Aβ) aggregation, based on apomorphine. These molecules target the nucleation phase of Aβ self-assembly and interfere effectively with aggregation of Aβ 1-40 into amyloid fibrils invitro as determined by transmission electron microscopy, Thioflavin T (ThT) fluorescence, and velocity sedimentation. Structure-activity studies using apomorphine analogues demonstrate that 10, 11-dihydroxy substitutions of the D ring are preferred for the inhibitory effectiveness of these aporphines, and that methylation of these hydroxyl groups reduces their inhibitory potency. The ability of these small molecules to inhibit Aβ amyloid fibril formation appears to be linked to their ability to undergo auto-oxidation in solution, implicating an auto-oxidation product as the active A&beta, inhibitor. Sedimentation velocity and electron microscopy studies demonstrate that apomorphine and analogues facilitate oligomerization of Aβ into short nonfibrillar soluble assemblies, but inhibit Aβ fibrilization.
机译:描述了基于阿扑吗啡的一类新型的淀粉样β蛋白(Aβ)聚集的小分子抑制剂。这些分子靶向Aβ自组装的成核相,并通过透射电子显微镜,硫黄素T(ThT)荧光和速度沉降测定,有效地干扰Aβ1-40体外聚集到淀粉样原纤维中。使用阿扑吗啡类似物进行的结构活性研究表明,D环的10,11-二羟基取代对于抑制这些卟啉具有较好的抑制作用,并且这些羟基的甲基化会降低其抑制能力。这些小分子抑制Aβ淀粉样蛋白原纤维形成的能力似乎与它们在溶液中进行自氧化的能力有关,这暗示着自氧化产物是活性的A&beta抑制剂。沉降速度和电子显微镜研究表明,阿扑吗啡及其类似物可促进Aβ寡聚为短的非原纤维可溶性装配体,但可抑制Aβ的纤维化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号